These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 9704254)
1. Granisetron and ondansetron for chemotherapy-related nausea and vomiting. Zeidman A; Ben Dayan D; Ben Zion T; Kaufman O; Cohen AM; Mittelman M Haematologia (Budap); 1998; 29(1):25-31. PubMed ID: 9704254 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy. Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429 [TBL] [Abstract][Full Text] [Related]
3. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy. Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047 [TBL] [Abstract][Full Text] [Related]
4. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation. Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147 [TBL] [Abstract][Full Text] [Related]
5. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial. Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869 [TBL] [Abstract][Full Text] [Related]
6. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Aksoylar S; Akman SA; Ozgenç F; Kansoy S Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235 [TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma. Slabý J; Trnený M; Procházka B; Klener P Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251 [TBL] [Abstract][Full Text] [Related]
8. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial. Lajolo PP; de Camargo B; del Giglio A Am J Clin Oncol; 2009 Feb; 32(1):23-6. PubMed ID: 19194119 [TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation. Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432 [TBL] [Abstract][Full Text] [Related]
10. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial. Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466 [TBL] [Abstract][Full Text] [Related]
11. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist? Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy. Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505 [TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy. Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma. Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311 [TBL] [Abstract][Full Text] [Related]
15. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery. White PF; Tang J; Hamza MA; Ogunnaike B; Lo M; Wender RH; Naruse R; Sloninsky A; Kariger R; Cunneen S; Khalili T Anesth Analg; 2006 May; 102(5):1387-93. PubMed ID: 16632815 [TBL] [Abstract][Full Text] [Related]
16. [Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron]. Mabro M; Granisétron PK Bull Cancer; 1999 Mar; 86(3):295-301. PubMed ID: 10210764 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy]. Takenaka M; Okamoto Y; Ikeda K; Hashimoto R; Ueda T; Kurokawa N; Takagi T; Uejima E Gan To Kagaku Ryoho; 2007 Mar; 34(3):403-7. PubMed ID: 17353632 [TBL] [Abstract][Full Text] [Related]
18. [Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord]. Huc P; Block S; Carlier D; Darloy F; Bonneterre ME; Bleuse JP; Fournier C; Bonneterre J Bull Cancer; 1998 Jun; 85(6):562-8. PubMed ID: 9752283 [TBL] [Abstract][Full Text] [Related]
19. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer]. Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306 [TBL] [Abstract][Full Text] [Related]
20. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy. Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]